STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning Balance at Dec. 31, 2020	$ (104,947)			$ 3,452		$ (108,399)
Beginning Balance, Shares at Dec. 31, 2020			2,130,139
Beginning Balance at Dec. 31, 2020		$ 105,296
Beginning Balance, Shares at Dec. 31, 2020		15,232,275
Issuance of Series C-2 convertible preferred stock, net of issuance cost of $42		$ 51,902
Issuance of Series C-2 convertible preferred stock, net of issuance cost of $42, Shares		5,611,059
Reclassification of convertible preferred stock purchase right liability to equity upon issuance of convertible C-2 preferred stock		$ 31,308
Conversion of convertible preferred stock to common stock	188,506			188,506
Conversion of convertible preferred stock to common stock, Shares			20,843,334
Temporary equity, Conversion of convertible preferred stock to common stock		$ (188,506)
Temporary equity, Conversion of convertible preferred stock to common stock, Shares		(20,843,334)
Issuance of common stock upon initial public offering, net of issuance costs of $22,541	241,959			241,959
Issuance of common stock upon initial public offering, net of issuance costs of $22,541, Shares			13,225,000
Issuance of common stock upon exercise of stock options	612			612
Issuance of common stock upon exercise of stock options, Shares			172,006
Issuance of common stock upon exercise of warrants, Shares			82,603
Issuance of common stock related to stock purchase agreement	13,638			13,638
Issuance of common stock related to stock purchase agreement, Shares			821,045
Issuance of common stock under employee stock purchase plan	640			640
Issuance of common stock under employee stock purchase plan, Shares			125,567
Vesting of early exercised options	123			123
Stock-based compensation	8,500			8,500
Unrealized loss on available-for-sale investments	(321)				$ (321)
Net loss	(98,591)					(98,591)
Ending Balance at Dec. 31, 2021	250,119			457,430	(321)	(206,990)
Ending Balance, Shares at Dec. 31, 2021			37,399,694
Issuance of common stock upon exercise of stock options	$ 135			135
Issuance of common stock upon exercise of stock options, Shares	56,897		59,187
Issuance of common stock upon vesting of restricted stock units			80,533
Issuance of common stock under employee stock purchase plan	$ 368			368
Issuance of common stock under employee stock purchase plan, Shares			258,488
Vesting of early exercised options	4			4
Stock-based compensation	9,576			9,576
Unrealized loss on available-for-sale investments	(598)				(598)
Net loss	(88,098)					(88,098)
Ending Balance at Dec. 31, 2022	$ 171,506			$ 467,513	$ (919)	$ (295,088)
Ending Balance, Shares at Dec. 31, 2022			37,797,902